UPDATE 1-U.S. FDA panel votes against approval of Nektar's opioid painkiller
January 14, 2020 at 17:34 PM EST
Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller for adults with chronic low back pain, sending the drug developer's shares down 12% in extended trading.
